Navigation Links
Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models"
Date:8/21/2014

Chester, NJ (PRWEB) August 21, 2014

Pursuit Solutions (http://www.pursuit-solutions.com), a provider of personal selling optimization technology and services for Life Sciences sales and marketing organizations, announced the publication of “Grading Pharma’s Use of New Commercial Sales Models” by Peter Robinson, co-founder and head of Measurement & Analytics.

The article examines some innovative models used to improve sales and marketing yield that are being tested in the pharmaceutical market. Robinson grades the industry on its progress against each model and proposes solutions to close remaining gaps.

To view the full article, visit http://www.pm360online.com/grading-pharmas-use-of-new-commercial-sales-models/.

About Pursuit Solutions

Pursuit Solutions provides sales and marketing optimization solutions for Life Sciences. Its flagship product, ClearSky, provides the pharmaceutical Field Force with an intuitive and powerful Closed-Loop Marketing (CLM) and Sales Force Automation (SFA) solution, that in concert with the client’s Multi-Channel Marketing (MCM) system enables the user to be aware of marketing touch-points, receive data-driven Interactive Visual Aid (IVA) and other tactic recommendations, and cater presentations to their customers’ interests. ClearView, the company’s business intelligence platform, is designed specifically for the pharmaceutical industry, combining Field Force, Marketing and Managed Markets metrics and insights in one place.

Pursuit's Data Management, Campaign Operations, and Strategy & Analytics capabilities enable its clients to take advantage of alignment across sales and marketing channels, so that customers have a valuable and consistent experience.

Pursuit Solutions is headquartered in Chester, NJ, with offices in Boston, MA, and in the southern San Francisco and Orange County, CA areas. For more information, visit http://www.pursuit-solutions.com.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12108877.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Pursuit's Elissa Guerra and Eunjoo Pluenneke to Present on Mobile Strategy at Digital Pharma West Conference
2. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
3. Dr. Peter C. Neligan, Author of 3rd Edition of Elseviers Plastic Surgery Text, Available for Comment on the Contributions of Dr. Joseph Murray
4. PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
5. Leader in Targeted Drug Development, Peter Hirth, Ph.D., Joins Trovagenes Scientific Advisory Board
6. American Botanical Council Publishes a History of Adulteration
7. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
8. Nonprofit Consortium Publishes Review of Skullcap Adulteration
9. Receptos Co-Publishes Highest Resolution G-Protein Coupled Receptor Structure to Date in Science
10. Seaside publishes research supporting disease-modifying potential of STX209 for fragile X syndrome
11. R&D Systems Publishes 100,000 Product Detail Web Pages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
Breaking Biology News(10 mins):